BarbaraM.WirostkoMD

PubMed

• 158 citations
  Vascular endothelial growth factor and diabetic complications
  Barbara M Wirostko, Tien Yin Wong, Rafael Simó
  Progress in Retinal and Eye Research. 2008-11-01
• 1 citations
  The utility of home tonometry for peri-interventional decision-making in glaucoma surgery: Case series.
  Ariana M Levin, Elyse J McGlumphy, Craig J Chaya, Barbara M Wirostko, Thomas V Johnson
  American Journal of Ophthalmology Case Reports. 2022-12-01
• 39 citations
  The Use of ChatGPT to Assist in Diagnosing Glaucoma Based on Clinical Case Reports.
  Mohammad Delsoz, Hina Raja, Yeganeh Madadi, Anthony A Tang, Barbara M Wirostko
  Ophthalmology and Therapy. 2023-12-01

Journal Articles

• Association of Exfoliation Syndrome with Risk of Indirect Inguinal HerniaThe Utah Project on Exfoliation Syndrome  
  R Rand Allingham, Barbara M Wirostko, Robert Ritch, JAMA
• Ophthalmic Uses of a Thiol-Modified Hyaluronan-Based Hydrogel  
  Wirostko B, Mann B, Williams D. Prestwich G, Advanced Wound Care, 1/1/2014
• Thiolated hyaluronan-based hydrogels crosslinked using oxidized glutathione: an injectable matrix designed for ophthalmic applications  
  Zarembinski T, Doty NJ, Erickson IE, Srinivas R, Wirostko BM, Tew WP, Acta Biomater, 1/1/2014
• Upper limits of intraocular pressure in glaucoma clinical trials  
  DeMill DL, Wirostko BM, Nelson LA, Stewart WC, Clin Experiment Ophthalmol, 1/1/2014
• Systemic Diseases Associated with Pseudoexfoliative Syndrome  
  Bettis DI, Allingham RR, Wirostko BM, International Ophthalmology Clinics, 1/1/2014
• Novel therapy to treat corneal epithelial defects; a hypothesis with growth hormone  
  Wirostko B, Rafii MJ, Sulivan D, Morelli J, Ding J, The Ocular Surface, 1/1/2014
• Human Growth Hormone Promotes Corneal Epithelial Cell Migration in Vitro  
  Ding J, Wirostko B, Sullivan D, Cornea, 1/1/2014
• Ocular hypertension following intravitreal anti-vascular endothelial growth factor therapy: review of the literature and possible role of nitric oxide  
  Morshedi G, Ricca A, Wirostko B, Journal of Glaucoma, 1/1/2014
• Cerebral blood flow in glaucoma patients  
  Harris A, Wirostko B, J Glaucoma, 1/1/2013
• The role of transforming growth factor Beta in glaucoma and the therapeutic implications  
  Mark A Prendes, Alon Harris, Barbara M Wirostko, Austin L Gerber, Brent Siesky, Br J Ophthalmol, 1/1/2013
• Contrast sensitivity basics and a critique of currently available tests  
  Richman J, Spaeth GL, Wirostko B, J Cataract Refract Surg, 1/1/2013
• Anterior Eye Segment Drug Delivery Systems: Current Treatments and Future Challenges  
  Molokhia S, Thomas S, Garff K, Mandell K, Wirostko B, J Ocular Pharm and Therap, 1/1/2013
• Review of the Influence of Pigment Dispersion and Exfoliation Glaucoma Diagnosis on Intraocular Pressure in Clinical Trials Evaluating Primary Open-angle Glaucoma and ...  
  William C. Stewart,; David L. DeMill, BA; Barbara M. Wirostko MD; Lindsay A. Nelson,BS; Jeanette A. Stewart, RN, J Glaucoma, 1/1/2013
• Average eye versus highest intraocular pressure analyses in glaucoma clinical trials  
  D. L. DeMill, BA, Barbara M. Wirostko, MD, Lindsay A. Nelson, BS, Jeanette A. Stewart, RN, William C. Stewart, MD, Ophthalmic Res, 1/1/2012
• Impaired ocular blood flow regulation in patients with open angle glaucoma and diabetes  
  Shoshani Y, Harris A, Shoja MM, Arieli Y, Ehrlich R, Primus S, Ciulla T, Cantor A, Wirostko B, Siesky BA, Clin Experiment Ophthalmol, 1/1/2012
• Ocular Drug Delivery for Glaucoma Management  
  Nathan Gooch, Sarah A. Molokhia, Russell Condie, R.M. Burr, Bonnie Archer, Balamurali K. Ambati, and Barbara Wirostko, Pharmaceutics, 1/1/2012
• Endothelin and its suspected role in the pathogenesis and possible treatment of glaucoma  
  Yochai Z. Shoshani, Alon Harris, Mohammadali M. Shoja, Deepam Rusia, Brent Siesky, Yoel Arieli, and Barbara Wirostko, Curr Eye Res, 1/1/2012
• Contrast sensitivity, ocular blood flow and their potential role in assessing ischemic retinal disease  
  Yochai Z. Shoshani, Alon Harris, Deepam Rusia, George Spaeth, Brent Siesky, Ayala Pollack, Barbara Wirostko, Acta Ophthalmologica, 1/1/2011
• Patient Preferences in the Treatment of Diabetic Retinopathy  
  Wirostko B, Beusterien K, Grinspan J, Ciulla T, Gonder J, Barsdorf A, Pleil A, Patient Preference and Adherence, 1/1/2011
• Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature  
  Tressler C, Wiseman R, Dombi T, Jessen B, Huang K, Kwok K, Wirostko B, British J Ophthalmology, 1/1/2011
• The effect of Pegaptnib (Macugen) injection on retinal and retrobulbar blood flow in retinal ischemic disease  
  Shoshani Y, Harris A, Ehrlich R, Yung C, Peracha M, Rusia D, Pollack A, Wirostko B, Siesky B, Retina, 1/1/2011
• Latanoprost Systemic Exposure in Pediatric and Adult Glaucoma Patients: A Phase I Open label Study  
  Susan Raber, PharmD, Rachel Courtney, PhD, Tomoko Maeda-Chubachi, MD, PhD, Brad D. Simons, MD, PhD, Sharon F. Freedman, MD, Barbara Wirostko, MD, for the A6111139 Stud..., Ophthalmology, 1/1/2011
• Comparison of Latanoprost and Timolol in Pediatric Glaucoma: A Phase 3, 12-Week, Randomized, Double-Masked Multicenter Study  
  Maeda-Chubachi T, MD, PhD, Chi-Burris K, MPH, Simons B,MD, PhD, Freedman S, MD, Khaw P, MD, PhD, Wirostko B, MD, Yan E, PhD, for the A6111137 Study Group, Ophthalmology, 1/1/2011
• Rho Kinase Inhibitors for Treatment of Glaucoma  
  Mandell KJ, Kudelka MR, Wirostko B, Expert Review, 1/1/2011
• Patient Preferences for Diabetic Retinopathy Health States  
  Szabo, S, Pleil, A, Wirostko, B et al, Invest Ophthalmol Vis Sci, 1/1/2010
• Join now to see all

Lectures

• Delivery of Human Growth Hormone via DSM's Poly(ester amide) 
  Seattle, WA - 1/1/2013
• Corneal Wound Healing Model in New Zealand White Rabbits for Evaluating Persistent Corneal Epithelial Defects 
  Seattle, WA - 1/1/2013
• Hystem, a bio-absorbable protein delivery polymer: safety, and efficacy in a corneal debridement model 
  Seattle, WA - 1/1/2013
• Systemic Blood Pressure and Ocular Perfusion Pressure Affects Blood Flow to the Optic Nerve Head in Glaucoma Patients with Diabetes 
  Seattle, WA - 1/1/2013
• Safety and Efficacy of a Novel Topical Rho Kinase Inhibitor ATS8535 in vivo 
  Fort Lauderdale, Florida - 1/1/2012
• Changes in Retrobulbar Blood Flow over Time in Patients with Glaucoma 
  Fort Lauderdale, Florida - 1/1/2012
• Changes in Retinal Capillary Blood Flow are Related to Changes in Optic Nerve Structure in Patients with Glaucoma 
  Fort Lauderdale, Florida - 1/1/2012
• Baseline Retrobulbar Blood Flow is Predictive of Macular Thickness in Patients with Glaucoma 
  Fort Lauderdale, Florida - 1/1/2012
• Clinical Research & Development 
  University of Utah. SLC, Utah - 1/1/2011
• Decreasing Retrobulbar Blood Flow is Predictive of OCT Structural Changes in Patients with Primary Open Angle Glaucoma 
  Fort Lauderdale, Florida - 1/1/2011
• Retinal Microcirculation As A Predictor For Retinal And Optic Nerve Structural Changes In Patients With Primary Open Angle Glaucoma 
  Fort Lauderdale, Florida - 1/1/2011
• Conjugation of Gadolinium Based Contrast Agent to Avastin for Pharmacokinetics with MRI 
  Fort Lauderdale, Florida - 1/1/2011
• Tolerability and IOP Lowering Activity of a Topical Rho Kinase Inhibitor, ATS907, in Normotensive Rabbits 
  Fort Lauderdale, Florida - 1/1/2011
• Pharmaceutical Profile of A Novel Rho Kinase (ROCK) Inhibitor ATS907 For Reduction Of IOP In Glaucoma 
  Fort Lauderdale, Florida - 1/1/2011
• Safety and Efficacy of a Novel Topical Rho Kinase Inhibitor ATS907 in Normotensive Cynomolgus Monkeys 
  Fort Lauderdale, Florida - 1/1/2011
• PANDA Study Group. Comparison of Latanoprost and Timolol in Pediatric Glaucoma Patients: a Phase 3, 12-week, Double-Masked Multicenter Study 
  Berlin Germany - 1/1/2010
• Malignant Melanoma and the Use of Latanoprost: A Risk Assessment 
  Berlin Germany - 1/1/2010
• Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension: Ocular Safety 
  Berlin Germany - 1/1/2010
• Pharmacokinetics (PK) of Latanoprost Acid in Pediatric and Adult Glaucoma Patients Treated with Latanoprost 0.005% 
  Fort Lauderdale, Florida - 1/1/2010
• Latanoprost (LAT) in Pediatric Glaucomas: Pharmacokinetics (PK)/Safety Evaluation and Phase 3 Study vs Timolol (TIM) 
  Chicago IL - 1/1/2010
• Systemic Exposure and Safety of Latanoprost 0.005% in Infants with Glaucoma 
  Berlin Germany - 1/1/2010
• Characterizing Functional Limitations for Adults with Diabetic Retinopathy 
  1/1/2009
• Patient Preferences in the Treatment of Diabetic Retinopathy 
  Fort Lauderdale, Florida - 1/1/2009
• A systematic review and meta-analysis of literature from 1975 to 2008 demonstrating reduced diabetic retinopathy progression rates 
  Nice France - 1/1/2009
• Treatment Modality and Structural/Functional Changes Over 82 Weeks in Patients With Diabetic Macular Edema (DME) 
  Fort Lauderdale, Florida - 1/1/2008
• Join now to see all